664 related articles for article (PubMed ID: 17414760)
1. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
[TBL] [Abstract][Full Text] [Related]
2. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate.
Weinreb JC; Barkoff ND; Megibow A; Demopoulos R
AJR Am J Roentgenol; 1990 Feb; 154(2):295-9. PubMed ID: 2105017
[TBL] [Abstract][Full Text] [Related]
3. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
[TBL] [Abstract][Full Text] [Related]
4. MRI features of ovarian fibroma and fibrothecoma with histopathologic correlation.
Shinagare AB; Meylaerts LJ; Laury AR; Mortele KJ
AJR Am J Roentgenol; 2012 Mar; 198(3):W296-303. PubMed ID: 22358029
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance evaluation of adnexal masses.
Guerra A; Cunha TM; Félix A
Acta Radiol; 2008 Jul; 49(6):700-9. PubMed ID: 18568564
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs. diffusion-weighted MRI with very small b-factors.
Shimada K; Ohashi I; Kasahara I; Watanabe H; Ohta S; Miyasaka N; Itoh E; Shibuya H
J Magn Reson Imaging; 2004 Jul; 20(1):97-104. PubMed ID: 15221814
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors.
Thomassin-Naggara I; Daraï E; Cuenod CA; Rouzier R; Callard P; Bazot M
J Magn Reson Imaging; 2008 Jul; 28(1):111-20. PubMed ID: 18581400
[TBL] [Abstract][Full Text] [Related]
9. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
10. MRI features of ovarian fibromas: emphasis on their relationship to the ovary.
Oh SN; Rha SE; Byun JY; Lee YJ; Jung SE; Jung CK; Kim MR
Clin Radiol; 2008 May; 63(5):529-35. PubMed ID: 18374716
[TBL] [Abstract][Full Text] [Related]
11. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics.
Swe TT; Onitsuka H; Kawamoto K; Ueyama T; Tsuruchi N; Masuda K
Radiat Med; 1992; 10(6):235-42. PubMed ID: 1287735
[TBL] [Abstract][Full Text] [Related]
12. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
Takeuchi M; Matsuzaki K; Nishitani H
J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
[TBL] [Abstract][Full Text] [Related]
13. The value of dynamic MRI studies in parotid tumors.
Alibek S; Zenk J; Bozzato A; Lell M; Grunewald M; Anders K; Rabe C; Iro H; Bautz W; Greess H
Acad Radiol; 2007 Jun; 14(6):701-10. PubMed ID: 17502260
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
15. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
[TBL] [Abstract][Full Text] [Related]
16. Ovarian fibroma (fibrothecoma) with extensive cystic degeneration: unusual MR imaging findings in two cases.
Takeshita T; Shima H; Oishi S; Machida N; Yamazaki K; Imamura T; Uchiyama K
Radiat Med; 2005 Feb; 23(1):70-4. PubMed ID: 15786755
[TBL] [Abstract][Full Text] [Related]
17. Prediction of early response to radiotherapy of uterine carcinoma with dynamic contrast-enhanced MR imaging using pixel analysis of MR perfusion imaging.
Takayama Y; Ohno T; Kishimoto R; Kato S; Yoneyama R; Kandatsu S; Tsujii H; Obata T
Magn Reson Imaging; 2009 Apr; 27(3):370-6. PubMed ID: 18768283
[TBL] [Abstract][Full Text] [Related]
18. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
19. Unilateral primary ovarian leiomyoma in adolescent: a case report.
Güney M; Ozsoy M; Oral B; Mungan T; Kapucuoğlu N
Arch Gynecol Obstet; 2007 Jun; 275(6):507-10. PubMed ID: 17139489
[TBL] [Abstract][Full Text] [Related]
20. Ovarian fibroma: findings by contrast-enhanced MRI.
Schwartz RK; Levine D; Hatabu H; Edelman RR
Abdom Imaging; 1997; 22(5):535-7. PubMed ID: 9233896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
